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Intramuscularly inoculated poliovirus is thought to spread to the central nervous system through neural pathways in
humans, monkeys, and the transgenic (Tg) mice carrying the human poliovirus receptor (PVR) gene. To gain insight into
molecular mechanisms for the retrograde axonal transport of poliovirus, resulting in the expression of neurovirulence, a
poliovirus-sensitive ICR-PVRTg21 mouse line (Tg21) was used as an animal model for poliomyelitis. We detected poliovirus
antigens in axons of the sciatic nerve. All of the Tg21 mice, which had been inoculated into the calves with 1 3 106 pfu of
the Mahoney strain of type 1 poliovirus, showed symptoms of paralysis in the inoculated limbs (initial paralysis) within 48 h
after the inoculation. The appearance of this initial paralysis was observed in mice whose sciatic nerves were transected at
various times after virus inoculation. The results were indicators of the velocity of poliovirus transportation through the
sciatic nerves under analysis. Poliovirus-related materials recovered from the sciatic nerve were mainly composed of intact
160S virion particles. The amount of 160S particle recovered was greatly reduced by coinjection with anti-PVR monoclonal
antibody. These results suggest that one of the fast retrograde axonal transport systems is involved in poliovirus dissemi-
nation through the sciatic nerve and that IM-inoculated poliovirus is incorporated into the sciatic nerve as intact particles in
a PVR-dependent manner, as it is in humans. © 1998 Academic Press
INTRODUCTION
Poliomyelitis is an acute disease of the central ner-
vous system (CNS) that is caused by poliovirus, a human
enterovirus that belongs to Picornaviridae. Poliovirus in-
fection in humans is thought to begin with oral ingestion.
After ingestion, the virus multiplies in the alimentary
mucosa, and the tonsils and Peyer’s patches are invaded
early in the course of infection. After multiplication in
these loci, the virus moves into the deep cervical and
mesenteric lymph nodes and then into the blood. Anti-
poliovirus antibodies in the blood prevent the develop-
ment of poliomyelitis, which suggests that viremia is
necessary for the spread of virus to the CNS. In ;1% of
infections, the virus invades the CNS and replicates in
neurons, especially the motor neurons. Paralytic polio-
myelitis occurs as a result of neuronal destruction. There
are two possible dissemination routes via which polio-
virus can enter the CNS. One is virus permeation through
the blood–brain barrier (BBB), and the other is virus
transmission via peripheral nerves.
How poliovirus permeates the BBB is unknown. Al-
though many tissues are exposed to the virus during the
viremic phase, most tissues do not support poliovirus
replication (Bodian, 1955). The development of poliovi-
rus-sensitive transgenic (Tg) mice that carry the human
poliovirus receptor (PVR) gene (Koike et al., 1991; Ren et
al., 1990) made it possible to study in detail the tissue
distribution of circulating poliovirus and the accumula-
tion of virus in CNS tissues, although the extent to which
poliovirus infection in Tg mice reflects those in humans
is not defined. In our previous study (Yang et al., 1997),
using the mouse model, we demonstrated that the
amounts of poliovirus delivered to the CNS tissues after
intravenous (IV) inoculation are the lowest among all the
tissues tested and that circulating poliovirus appears to
cross the BBB at a high rate that is independent of PVR
expression. The study also suggested that the neural
pathway from the skeletal muscle is not the primary
dissemination route of the virus to the CNS.
Although it may not be the main dissemination path-
way for poliomyelitis, a neural pathway has been re-
ported for humans, monkeys, and Tg mice. Experimental
evidence indicated that poliovirus can spread to the CNS
through the sciatic nerve of monkeys (Howe and Bodian,
1942). In the Cutter vaccine incident, in which children
received incompletely inactivated polio vaccine, a high
frequency of initial paralysis was observed in the inocu-
lated limb (Nathanson and Langmuir, 1963). Furthermore,
Ren and Racaniello (1992) strongly suggest that poliovi-
rus can spread from the muscle to the CNS through
neural pathways in Tg mice and that expression of the
PVR plays an important role in viral spread by this route.
A very recent report describes how provocation poliomy-
elitis, a phenomenon resulting from physical trauma dur-
ing infection with poliovirus, can be experimentally re-
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5408. E-mail: anomoto@ims.u-tokyo.ac.jp.
VIROLOGY 250, 67–75 (1998)
ARTICLE NO. VY989360
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
67
produced in Tg mice, suggesting that skeletal muscle
injury stimulates retrograde axonal transport of poliovi-
rus and thereby facilitates viral invasion of the CNS and
progression of spinal cord damage (Gromeier and Wim-
mer, 1998). These findings have renewed interest in
neural pathways as a means of conveying poliovirus.
To control poliomyelitis, attenuated poliovirus strains
of all three serotypes are effectively used as oral live
poliovirus vaccines (Sabin and Boulger, 1973). The viru-
lent and attenuated phenotypes of poliovirus observed in
monkeys appeared to be preserved in the Tg mice. In
fact, mouse neurovirulence tests involving intracerebral
(IC) and intraspinal (ISp) inoculation routes have been
established (Abe et al., 1995a, 1995b; Horie et al., 1994).
Different neurovirulence levels are apparent between
virulent and attenuated poliovirus strains when the vi-
ruses are intravenously (IV) inoculated into the Tg mice
(Koike et al., 1994a; Yang et al., 1997). In a corresponding
way, the potential to estimate relative levels of neuroviru-
lence also may reside in the use of Tg mice that are
inoculated intramuscularly (IM).
We used a poliovirus-sensitive Tg mouse line to dem-
onstrate that poliovirus inoculated into the calves was
transported through axons as intact virions; we describe
how one of the more rapid retrograde axonal transport
systems for poliovirus involved PVR-dependent viral dis-
semination and how viral capsid protein from virulent
and attenuated strains of type 1 poliovirus affected this
pathway.
RESULTS
Initial paralysis after IM inoculation of poliovirus
The virulent Mahoney strain of poliovirus type 1 was
inoculated into the left calves of ICR-PVRTg21 (Tg21)
mice (Koike et al., 1991, 1994b). All the Tg mice that had
been inoculated with 1 3 106 plaque-forming units (pfu)
of virus showed a flaccid paralysis in the inoculated
limbs within 48 h p.i. (Figs. 1 and 4A) and died within 4
days p.i. (See Fig. 4A). To confirm involvement of the
sciatic nerve in development of the initial paralysis, the
sciatic nerve was transected before IM inoculation of the
virus. As shown in Fig. 1, none of the mice with sciatic
nerve transection showed paralysis at 48 h p.i. via the IM
route. The paralysis observed at 48 h p.i., therefore, was
due to the effect of virus carried by retrograde axonal
transport system through the sciatic nerve. Our results
are compatible with those reported by Ren and Ra-
caniello (1992). Furthermore, the Tg21 mice that were
intravenously inoculated with 1 3 106 pfu of the virus
were not paralyzed at 48 h p.i. (Fig. 1). The data indicated
that virus leaking from the inoculation site to the blood
stream scarcely affected the initial paralysis.
We measured virus titers in tissue samples of the
muscle and spinal cord prepared at various times after
IM inoculation of 1 3 106 pfu of the Mahoney poliovirus
strain (Table 1). In the muscle, .2 3 105 pfu of the virus
was detected continuously at 4–48 h p.i. The data sug-
gested that the Mahoney strain replicated in the muscle,
albeit inefficiently. Indeed, in a similar experiment, virus
titers detected in the muscle of the control non-Tg mice
at 24 and 48 h p.i. were ,1 3 103 pfu and ,1 3 102 pfu,
respectively (data not shown). A significant amount of
FIG. 1. Paralysis caused by intramuscularly and intravenously inoc-
ulated virus and the effect of sciatic nerve transection on paralysis
caused by intramuscularly inoculated virus. Tg21 mice with () or
without (E and M) sciatic nerve transection were inoculated with 1 3
106 pfu of the virulent Mahoney virus via the IM (E and ) or IV (M)
inoculation route. The infected mice were observed for paralysis every
24 h until 7 days p.i.
TABLE 1
Virus Distribution After Intramuscular Inoculation
Time after IM
inoculation Mousea Spinal cord Muscle
4 h 1 1 3 101b 3 3 105
2 NDc 7 3 105
3 5 3 101 3 3 105
8 h 1 ND 5 3 105
2 ND 4 3 105
3 5 3 101 4 3 105
12 h 1 ND 2 3 105
2 ND 3 3 105
3 ND 2 3 105
16 h 1 2 3 104 9 3 105
2 ND 4 3 105
3 4 3 104 3 3 105
20 h 1 5 3 104 3 3 105
2 2 3 105 3 3 105
3 5 3 104 3 3 105
24 h 1 4 3 104 2 3 105
2 5 3 104 3 3 105
3 5 3 104 3 3 105
48 h 1 4 3 107 5 3 105
2 4 3 107 9 3 105
3 5 3 107 3 3 106
a Each mouse was inoculated with 1 3 106 pfu of the Mahoney virus.
b Titers in AGMK cells are indicated by pfu/tissue.
c ND means ,10 pfu/tissue.
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virus was detected at 16 h p.i. in the spinal cord; by 48 h
p.i., when the Tg mice showed the initial signs of paral-
ysis in the inoculated limbs, 4–5 3 107 pfu of the virus
was detected. Thus, the virus growth in the spinal cord
seemed to correlate with the expression of clinical symp-
toms. Very similar data were obtained when we used a
light-sensitive Mahoney virus (data not shown), which
indicated that virus titers detected at 16 h p.i. repre-
sented virus that had undergone replication and were
not due to the inoculum.
Transporting velocity
As a way of measuring the velocity of poliovirus trans-
port through the sciatic nerve, we transected the sciatic
nerve at increasing times p.i. and noted the extent of hind
limb paralysis. The sciatic nerve of Tg21 mice was
transected 2, 4, 6, and 10 h after IM inoculation of 1 3 106
pfu of the Mahoney virus, and the mice were observed
for initial paralysis 48 h after the inoculation (Table 2).
Transection at 2, 4, and 6 h p.i., respectively, protected all
six mice, four of six mice, and two of six mice from
paralysis; transection at 10 h did not show any protective
effects. These results indicated that at least a part of
IM-inoculated poliovirus reaches the transection point
within 4 h after the inoculation. Considering that the
distance between transection point and inoculation point
is ;2 cm, some of the IM-inoculated virus moves faster
than 12 cm/day.
Immunohistochemical analysis also was used for
measuring the velocity of poliovirus transport (Fig. 2).
Transverse sections of the sciatic nerve were prepared
from the transection points at various times after the IM
inoculation of the virus and examined for poliovirus an-
tigens. As shown in Fig. 2, poliovirus antigens were
detected in many myelin-sheathed axons of the infected
Tg21 mice but not in axons of mock-infected mice. A
similar result was obtained when the section was pre-
pared 6 h p.i. (data not shown). In the sciatic nerve of
infected mice, no or only a few axons containing polio-
virus antigens were detected at 1.5 h p.i. (data not
shown). Thus, it took only 3 h for some of the intramus-
cularly inoculated virus to reach the transection point,
indicating that transmission rate of poliovirus-related
materials was ;16 cm/day (Fig. 2). The data also proved
that poliovirus antigens exist in axons of the sciatic
nerve.
Transection at 6 h, however, still protected two of six
mice. Perhaps some type of slightly slower retrograde
axonal transport system also is used in poliovirus trans-
mission through the sciatic nerve. Alternatively, the trans-
port capacity of the sciatic nerve may not be sufficiently
high to carry enough of the virus to cause rapid initial
paralysis. In any event, the velocity of the poliovirus
transport fell into the classification of fast retrograde
axonal transport because the rate of slow retrograde
axonal transport is ,0.6 cm/day according to Brady
(1991).
Poliovirus-related materials in the sciatic nerve
In poliovirus-sensitive Tg mice, expression of the PVR
plays an important role in viral spread from the muscle to
the CNS through nerve pathways (Ren and Racaniello,
1992). Indeed, coinjection of mouse anti-human PVR
monoclonal antibody (mAb) p286 with poliovirus in the
calves of Tg21 mice protected the mice from initial pa-
ralysis in a dose-dependent manner (data not shown).
Involvement of PVR in the spread of the virus suggested
the possibility that poliovirus-related materials in the
sciatic nerve are not intact 160S virion particles because
the PVR has the ability to alter the conformation of po-
liovirus from the 160S intact particle to a 135S particle in
which the viral capsid protein VP4 is missing (Arita et al.,
1998; Lonberg-Holm et al., 1975). Accordingly, we deter-
mined the form of poliovirus-related materials recovered
from the sciatic nerve that had been ligated to decrease
the axonal flow.
The mice inoculated with [35S]methionine-labeled vi-
rus were killed at 1.5 h p.i., and the sciatic nerves were
homogenized. The homogenates were analyzed by su-
crose density gradient centrifugation as described in
Materials and Methods. As shown in Fig. 3A, a majority
of poliovirus-related materials in the sciatic nerve had a
sedimentation coefficient of 160S. The intact virion par-
ticle appeared to be transported through the axon. In
fact, a virus suspension recovered from the sciatic nerve
was found to be infectious for cultured cells of primate
origin (data not shown). This 160S peak was greatly
reduced when 42.2 mg of mAb p286 was coinjected with
the virus (Fig. 3B). The data further confirmed that PVR
was involved in the processes of viral incorporation into
the synapses and poliovirus axonal transport. Why PVR-
mediated conformational change was not observed for
the virion-related particle recovered from the sciatic
nerve is not clear.
TABLE 2
Sciatic Nerve Transection at Various Times After Intramuscular
Inoculation of the Mahoney Virus
Transection
Mice (paralyzed/inoculated)
48 h after virus inoculation (n)a
2 hb 0/6
4 h 2/6
6 h 4/6
10 h 6/6
a Tg21 mouse was inoculated intramuscularly with 1 3 106 pfu of the
Mahoney virus.
b Sciatic nerve transection was performed at 2 h after the virus
inoculation.
69NEURAL PATHWAY OF POLIOVIRUS IN MOUSE MODEL
FI
G
.2
.P
ol
io
vi
ru
s
an
tig
en
s
in
ax
on
s.
Th
e
se
ct
io
ns
of
th
e
sc
ia
tic
ne
rv
es
w
er
e
pr
ep
ar
ed
fr
om
a
po
lio
vi
ru
s-
in
fe
ct
ed
Tg
m
ou
se
(A
–C
)o
ra
m
oc
k-
in
fe
ct
ed
Tg
m
ou
se
(D
–F
).
Th
e
se
ct
io
ns
w
er
e
im
m
un
os
ta
in
ed
as
de
sc
rib
ed
in
M
at
er
ia
ls
an
d
M
et
ho
ds
.(
A
an
d
D
)M
ye
lin
sh
ea
th
s
ca
n
be
se
en
.B
rig
ht
flu
or
es
ce
nc
e
is
vi
si
bl
e
in
B
bu
t
no
t
in
E
.(
C
an
d
F)
M
er
gi
ng
pi
ct
ur
es
of
A
an
d
B
an
d
of
D
an
d
E
,r
es
pe
ct
iv
el
y.
(C
)
Po
lio
vi
ru
s
an
tig
en
s
ex
is
tin
g
in
ax
on
s
su
rr
ou
nd
ed
by
m
ye
lin
sh
ea
th
.B
ar
5
50
m
m
.
70 OHKA ET AL.
Mouse neurovirulence of intramuscularly inoculated
polioviruses
Poliovirus incorporated into synapses and muscle
cells possibly is protected from neutralization by circu-
lating anti-poliovirus antibodies. To examine this possi-
bility, rabbit anti-poliovirus hyperimmune serum was in-
travenously injected just before IM inoculation of the
virus (Table 3). The serum sufficiently protected the mice
from the disease caused by intravenously inoculated
virus for up to 2 weeks after virus inoculation (Table 3). In
contrast to this, only two of 10 mice were protected by IV
injection of the rabbit serum. Thus, the antiserum in the
blood showed only a limiting protective effect on devel-
opment of the paralysis caused by IM inoculation of the
virus. These results suggested that the neural pathway
from the muscle to the CNS is uniquely shielded from
humoral immunity.
Using the IM inoculation route, we tested mouse neu-
rovirulence of the virulent Mahoney virus, the attenuated
Sabin 1 virus, and their recombinant viruses, MSM and
SMS (Fig. 4). The genome of MSM virus has the Sabin 1
capsid protein coding sequence in the background of the
Mahoney genome, and the genome of SMS virus was the
reciprocal structure of the MSM genome (Yang et al.,
1997). Only one of 10 Tg mice inoculated with 1 3 106 pfu
of the Sabin 1 virus showed a sign of paralysis within
48 h p.i. (Fig. 4D), whereas all the mice inoculated at the
same multiplicity of infection with the Mahoney virus
showed initial paralysis (Figs. 1 and 4A). With IM inocu-
lation, these virulent and attenuated polioviruses also
displayed different neurovirulence levels.
To assess the effect of viral capsid protein on the
development of disease, viruses MSM (Fig. 4B) and SMS
(Fig. 4C) were tested for neurovirulence via the IM inoc-
ulation route. As shown in Fig. 4, virus MSM showed a
slightly less virulent phenotype than the Mahoney virus.
That observation is compatible with those obtained from
mouse neurovirulence tests with IC inoculation (Horie et
al., 1994) and IV inoculation (Yang et al., 1997). A rela-
tively weak neurovirulence determinant or determinants
are thought to exist in the viral capsid protein coding
sequence (Kohara et al., 1988). In fact, Bouchard et al.
(1995) reported that mutations at nucleotides 935, 2438,
2795, and 2879 within the capsid protein coding se-
quence of the Sabin 1 genome were determinants of
attenuation, although they did not test reciprocal
changes of these mutations. We unexpectedly found that
the relative neurovirulence level of SMS virus was lower
than that of the Sabin 1 virus (Fig. 4). This observation
disagreed with those of earlier reports based on the IC
inoculation route (Horie et al., 1994; Yang et al., 1997).
The results suggested that viruses carrying the Sabin 1
capsid may have some advantage in the development of
the disease initiated by IM inoculation over those carry-
ing the Mahoney capsid.
DISCUSSION
The development of paralytic disease caused by intra-
muscularly inoculated poliovirus was investigated using
a poliovirus-sensitive Tg mouse model. Some part of
intramuscularly inoculated virus must be taken up di-
TABLE 3
Effect of Anti-poliovirus Antibody on Neurovirulence Caused by
Intramuscularly Inoculated Poliovirus
Virusa
inoculation route Anti-PV Abb
48 h after
inoculation
Up to 2 weeks
after inoculation
IM 2 10/10c 10/10
IM 1 8/10 8/10
IV 2 0/10 10/10
IV 1 0/10 0/10
a Tg21 mouse was inoculated with 1 3 106 pfu of the Mahoney virus.
b Anti-poliovirus serum was injected into the tail vein just before the
virus inoculation.
c Number of mice paralyzed/inoculated.
FIG. 3. Analysis of virus-related materials in the sciatic nerve. Tg21
mice with sciatic nerve ligation were intramuscularly inoculated with
1 3 107 pfu of [35S]methionine-labeled Mahoney virus, which was
mixed with (B) or without (A) anti-PVR mAb p286. Radioactive materials
were recovered from the sciatic nerve and analyzed by sucrose density
gradient centrifugation as described in Materials and Methods. (Arrow)
The 160S position.
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rectly by the synapses because within 4 h p.i., before the
virus could have replicated, it had reached the sciatic
nerve transection point, located ;2 cm from the inocu-
lation site (Table 2, Fig. 2). Poliovirus appears to replicate
in the muscle of the Tg mice at low efficiency (Table 1),
and the virus replicated in the muscle cells may be
incorporated into the synapses at the neuromuscular
junction. These mechanisms may have involved in the
Cutter incident (Nathanson and Langmuir, 1963). The
effect of experimental provocation may reflect stimula-
tion of poliovirus replication in injured muscle tissue and
retrograde axonal transport of the virus (Gromeier and
Wimmer, 1998), although it has been speculated in stud-
ies with primates that entry of poliovirus into the CNS
may be facilitated by localized alteration of vascular
permeability in the CNS induced by muscle trauma
(Bodian, 1954).
Although the neural pathway is suggested not to be a
main viral dissemination route for intravenously inocu-
lated virus invasion of the CNS (Yang et al., 1997), it
appeared to be critical in intramuscularly inoculated vi-
rus development of paralysis in the inoculated limbs. Our
data confirmed a previous report (Ren and Racaniello,
1992) that PVR was involved in the development of the
initial paralysis. Localization of initial paralysis was re-
ported in monkeys that were intramuscularly inoculated
with the neurotropic poliovirus type 2 MV strain
(Nathanson and Bodian, 1961). Because this paralysis
was blocked by freezing the sciatic nerve, transmission
of the MV strain from muscle to the CNS appeared to be
restricted to the sciatic nerve system. In the Cutter inci-
dent, 71% of human paralysis cases showed a correla-
tion between sites of inoculation and first paralysis
(Nathanson and Langmuir, 1963). Monkeys intramuscu-
larly inoculated with the Mahoney virus, however, did not
exhibit localization of paralysis (Nathanson and Bodian,
1961). This may have been due to significant extraneural
proliferation of the virus or to possible use by the virus of
other neurons innervating the injected muscle. Nerve
transection did not block intramuscularly inoculated vi-
rus invasion of the CNS because all the intramuscularly
infected Tg mice with sciatic nerve transection were
paralyzed within 7 days p.i. (Fig. 1); this also points to
muscle–CNS dissemination routes other than the sciatic
nerve for transmission of virus.
PVR has been thought to have a dual function, that is,
a virus-binding activity and a virus-conformation conver-
sion activity. In fact, purified PVR can change the 160S
intact virion particle to the 135S and 80S particles (Arita
et al., 1998). Thus, PVR itself appears to contribute to
uncoating of poliovirus. The bulk of virus-related materi-
als in the sciatic nerve showed a sedimentation coeffi-
cient of 160S. Perhaps a small number of PVR bound per
virion does not result in viral conformational change but
nevertheless induces endocytosis of the virus on the cell
surface. Poliovirus infection may be established by any
of several pathways, such as PVR-mediated fusion, re-
sulting in release of the viral genome into the cell cyto-
plasm, and PVR-mediated endocytosis, followed by un-
coating in endosomes. The latter might be the main way
that poliovirus enters motor neurons in vivo. Alternatively,
a cellular factor or factors that inhibit uncoating of the
virus may exist in the neural pathway of the Tg mice; the
virus would need to be free from such a factor or factors
before replicating in the neuron cell body.
Possible processes, like virus infection in muscle
cells, virus incorporation into synapses, and virus un-
coating in neurons during the development of the dis-
ease, may require PVR functions after IM inoculation of
poliovirus. PVR is expressed in the muscle (Koike et al.,
1994a), and using immunostaining with mAb p286, we
FIG. 4. Relative mouse neurovirulence levels of polioviruses via IM
inoculation route. Each Tg21 mouse was intramuscularly inoculated
with 1 3 106 pfu of the virulent Mahoney virus (A), virus MSM (B), virus
SMS (C), or attenuated Sabin 1 virus (D) and observed for paralysis and
death every 24 h for 14 days after the inoculation. Solid and shaded
bars represent nonparalyzed and paralyzed terms of survivals, respec-
tively.
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found that primary-cultured motor neurons derived from
neonatal Tg21 mice express PVR on their surface, includ-
ing axons and synapses (data not shown). Also, human
synaptosomes might contain poliovirus-binding sites
(Brown et al., 1987).
Our data strongly suggested that poliovirus was trans-
ported through the sciatic nerve by fast retrograde ax-
onal transport, a process that is involved in the transport
of prelysosomal vesicles, multivesicular bodies, growth
factors, and recycled proteins. Many substances that are
carried retrogradely by the fast transport system are
thought to be packed in endosomes. Poliovirus might be
enclosed by endosomes in the sciatic nerve that result
from PVR-mediated endocytosis of the virus occurring at
synapses. It is interesting to speculate on the natural
function of PVR. The natural ligand of PVR may be retro-
gradely transported through axons like poliovirus.
Mouse neurovirulence testing via IM inoculation dem-
onstrated that the Mahoney virus showed a slightly
stronger neurovirulence phenotype than MSM virus (Fig.
4). This observation can be explained by the different
stabilities of virus strains. Indeed, viruses carrying the
Sabin 1 capsid are less stable than those carrying the
Mahoney capsid in the brain of non-Tg mice (Yang et al.,
1997). Differences in virion stabilities are likely to be one
of the determinants for neurovirulence phenotype. The
SMS virus, however, was slightly less neurovirulent than
the Sabin 1 virus, a phenomenon that should not be due
to different stabilities of the two viruses. Interestingly, the
mean survival term after the onset of paralysis was
shorter for SMS virus than for the Sabin 1 virus and was
shortest for the virulent Mahoney virus (Fig. 4). That
observation suggested that once replication occurs in
the CNS, SMS virus has a stronger neurovirulent pheno-
type than the Sabin 1 virus. It is possible that viruses
carrying the Sabin 1 capsid are transported more effi-
ciently through the axon than those carrying the Ma-
honey capsid. Thus, relative neurovirulence levels of
intramuscularly inoculated viruses MSM and SMS may
be overestimated and underestimated, respectively. In
any event, mechanisms for the expression of mouse
neurovirulence via the IM inoculation route appear to be
more complicated than those via IC inoculation. Finally,
this work may contribute to the development of neuro-
tropic expression vectors derived from poliovirus.
MATERIALS AND METHODS
Transgenic mice
The Tg mouse line ICR-PVRTg21 (Tg21) (Koike et al.,
1991, 1994b) in the hemizygous stage with IQI mice was
used as an animal model for poliomyelitis. IQI mice were
used as non-Tg mice. All the mice were free from specific
pathogens and were 6–10 weeks of age.
Viruses and cells
The virulent Mahoney strain and the attenuated Sabin
1 strain of type 1 poliovirus were derived from infectious
cDNA clones pOM1 (Shiroki et al., 1995) and pVS(1)IC-
0(T) (Kohara et al., 1988), respectively. Light-sensitive
Mahoney virus was prepared according to a previously
described method (Madshus et al., 1984; Koike et al.,
1990); of 108 pfu, only 1 pfu of the virus remained after
exposure to light. A cDNA segment of pOM1 correspond-
ing to a coding sequence for the viral capsid proteins
(the P1 region) was replaced by the corresponding seg-
ment of pVS(1)IC-0(T). The resulting recombinant cDNA
clone was transfected to prepare MSM virus (Yang et al.,
1997). A similar experiment was carried out to produce
virus SMS, whose genome encoded the reciprocal struc-
ture of the MSM genome (Yang et al., 1997).
Suspension-cultured HeLa S3 cells were maintained
in RPMI 1640 medium supplemented with 5% newborn
calf serum (NCS) and used for preparation of [35S]methi-
onine-labeled virus. African green monkey kidney
(AGMK) cells were grown in DMEM supplemented with
5% NCS and used for preparation of viruses, transfection
experiment with infectious cDNA clones, and plaque
assays.
Purification of radiolabeled viruses
[35S]Methionine-labeled virus was grown in suspen-
sion-cultured HeLa S3 cells in methionine-free medium
containing [35S]methionine as described previously
(Yang et al., 1997). Virus in cytoplasmic extracts of in-
fected cells was purified by chromatography on DEAE–
Sepharose CL-6B (Li et al., 1992), followed by two cycles
of CsCl equilibrium centrifugation as described previ-
ously (Yang et al., 1997). The specific radioactivity of
purified radiolabeled Mahoney virus was calculated to
be 7.3 3 1028 mCi/pfu.
Virus inoculation and tissue sampling
With the use of a Hamilton microsyringe, 5 ml of a virus
suspension was intramuscularly inoculated into the left
calf of each Tg mice under anesthesia from an intraperi-
toneal injection of 300–400 ml of 10 mg/ml ketamine and
0.2 mg/ml xylazine in saline. After the mice were anes-
thetized with chloroform, the left muscle, left sciatic
nerve, and spinal cord were removed. The tissues were
homogenized in DMEM using Pellet Pestle Motor (Kon-
tes Scientific). Intravenous inoculation was carried out by
inoculating 100 ml of a virus suspension into the vein of
the tail. Virus titers in tissue homogenates, after removal
of the debris, were determined by plaque assay in AGMK
cells. In the case of inoculation of [35S]methionine-la-
beled virus, 5 ml each of the labeled virus was inoculated
into four points of the left calf of each Tg21 mice. A total
of 20 ml of the virus suspension contained 5 3 106 pfu
(0.37 mCi) of the Mahoney virus.
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Sciatic nerve transection and ligation
Transection of the sciatic nerve was carried out as
described previously (Tyler et al., 1986). After anesthetiz-
ing the mice with ketamine and xylazine as above, an
incision was made in the back above the left thighbone,
and the muscle layers were cut to expose the sciatic
nerve along the thighbone. Near the junction of the thigh
bone and pelvis, a ;5 mm long nerve section was
removed, and the skin incision was closed with quick-
drying adhesive. After the operation, all the mice showed
paresis, which is easily distinguishable from poliovirus
paralysis. Then the viruses were inoculated into the
calves ;2 cm from the transection point.
For analysis of the materials in the sciatic nerve, the
nerve was ligated tightly with silk thread near the junc-
tion of thighbone and pelvis as described previously
(Hirokawa et al., 1990, 1991), and 35S-labeled poliovirus
was inoculated into the calf.
Antibodies
Mouse anti-human PVR mAb, p286 (Yang et al., 1997),
was mixed with a virus suspension, and 5 ml of the
mixture was intramuscularly inoculated to the Tg21 mice.
In the case of coinjection with [35S]methionine-labeled
virus, the mAb was added to a virus suspension up to
42.2 mg in a total of 20 ml of injection volume. To neu-
tralize the virus in the blood that leaked from the inocu-
lation site, 100 ml of rabbit anti-poliovirus type 1 hyper-
immune serum was intravenously injected immediately
before IM inoculation of the virus. This amount of the
anti-poliovirus serum has an ability to neutralize 1 3 106
pfu of the Mahoney virus.
Immunohistochemical analysis
The sciatic nerve at a distance of ;2 cm from the
inoculation points was removed and embedded in O.C.T.
compound. The sections of the sciatic nerve, fixed with
acetone–methanol (3:2) at room temperature, were re-
acted with rabbit hyperimmune serum against poliovirus
type 1 at 37°C for 2 h and then treated with goat anti-
rabbit IgG conjugated with fluorescein isothiocyanate at
37°C for 2 h. The sections were mounted with 80% (v/v)
glycerol and analyzed with a confocal laser scanning
microscope (BioRad).
Sucrose density gradient centrifugation
At 1.5 h after the IM inoculation of [35S]methionine-
labeled Mahoney virus, the sciatic nerve that had been
ligated as above was homogenized at 4°C in a phos-
phate-buffered saline (8 g of NaCl, 0.2 g of KCl, 1.15 g of
Na2HPO4, and 0.2 g of KH2PO4 per liter) containing 1%
Nonidet P40 and 0.1% BSA fraction V (Sigma Chemical).
After centrifuging the homogenate to remove the debris,
the supernatant was applied onto 15–30% sucrose den-
sity gradient in the buffer described above. The centrif-
ugation was performed at 39,000 rpm for 2 h at 4°C in a
Beckman rotor SW41. Radioactivity of each fraction was
measured in a liquid scintillation counter.
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